Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of CD137 Agonist ADG106 Administered Intravenously in Patients With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

NCT03707093 is registered in ClinicalTrials.gov with Adagene Inc as lead sponsor.

NCT NCT03707093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of CD137 Agonist ADG106 Administered Intravenously in Patients With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
Lead sponsor
Adagene Inc
Phase
Phase 1
Overall status
Completed
Start date
September 17, 2018
Completion date
September 30, 2022
Enrollment
49 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors, non-hodgkin lymphoma